Spineway SA (FRA:37S)

Market Cap	3.23M +49.3%
Revenue (ttm)	12.81M +0.6%
Net Income	-2.24M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	173,883
Average Volume	58
Open	0.1382
Previous Close	0.1378
Day's Range	0.1382 - 0.1550
52-Week Range	0.0992 - 0.2625
Beta	n/a
RSI	34.24
Earnings Date	Apr 29, 2026

About Spineway

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2005
• Employees: 43
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 37S

Financial Performance

In 2025, Spineway's revenue was 12.81 million, an increase of 0.62% compared to the previous year's 12.73 million. Losses were -2.24 million, -42.10% less than in 2024.